Molmart Ltd
1 known investors
Find your way into Molmart Ltd
Sign up to see every warm intro you have to Molmart Ltd
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Molmart Ltd team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MolMart offers at-home genetic carrier screening via a saliva test for individuals and couples planning a family, delivering results through an app with expert support. It focuses on identifying inherited conditions that may affect a baby's health.
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- MOLMART LTD.
- Company number
- 10303155
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 29 Jul 2016
- Registered office
- 32a The Renold Building, Altrincham Street, Manchester, M1 7JR
- Nature of business (SIC)
- 86900 — Other human health activities
- Previous names
- MM GENOMICS LIMITED (2016–2016)
- Accounts
- last made up to 31 Jul 2025 · next due 30 Apr 2027
- Confirmation statement
- last made up to 27 Feb 2026 · next due 13 Mar 2027
Current officers · 2
- Markella Andrea Mikkelsen — director, appointed 29 Jul 2016
- Deepbridge Ned Limited — corporate director, appointed 3 Apr 2024
Source: Companies House public register · retrieved 8 Nov 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Molmart Ltd do?
- MolMart offers at-home genetic carrier screening via a saliva test for individuals and couples planning a family, delivering results through an app with expert support. It focuses on identifying inherited conditions that may affect a baby's health.
- Who are Molmart Ltd's investors?
- Molmart Ltd's investors include Deepbridge Capital.